Fierce Pharma
Fierce Biotech
Fierce Healthcare
Fierce Life Sciences Events
Advertise
About Us
Pharma
Vaccines
Asia
Cell & Gene Therapy
Drug Delivery
Executives
Manufacturing
Facilities
Recalls
Warning Letters
Marketing
Special Reports
Fierce 50
Special Report
Awards Gala
Resources
Podcasts
Fierce Events
Industry Events
Webinars
Whitepapers
Survey
Events
Subscribe
Subscribe
Pharma
Vaccines
Asia
Cell & Gene Therapy
Drug Delivery
Executives
Manufacturing
Facilities
Recalls
Warning Letters
Marketing
Special Reports
Fierce 50
Special Report
Awards Gala
Resources
Podcasts
Fierce Events
Industry Events
Webinars
Whitepapers
Survey
Events
Subscribe
Fierce Pharma
Fierce Biotech
Fierce Healthcare
Fierce Life Sciences Events
Advertise
About Us
psoriatic arthritis
Pharma
AstraZeneca, BeiGene, Coherus—Fierce Pharma Asia
AZ licensed a KRAS G12D drug from Usynova. BeiGene bought a CDK2 inhibitor from Ensem. Coherus priced its Chinese PD-1 at a 20% discount to Keytruda.
Angus Liu
Dec 1, 2023 8:34am
AbbVie Skyrizi TV ads take subtler tone compared with Rinvoq
Aug 16, 2022 8:58am
Amgen finds a dance partner in Lance Bass for PsA campaign
May 13, 2022 12:38pm
Trial win sets up AbbVie's Rinvoq up for likely Crohn's approval
May 12, 2022 9:52am
Skyrizi clinches its 2nd approval with psoriatic arthritis
Jan 24, 2022 8:51am
AbbVie says Rinvoq, Skyrizi combined will outperform Humira
Jan 11, 2022 6:15pm